UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

~~________________~~_____________________

FORM 8-K

~~________________~~_____________________

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 216, 2010

ADVANCE NANOTECH, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-10065	20-1614256
(State or other jurisdiction	(Commission	(I.R.S. Employer
of incorporation)	File Number)	Identification No.)

400 Rella Blvd., Suite 160, Montebello, NY		10901
400 Rella Blvd, Suite 160, Montebello, New York, NY		10901
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code: (212) 583-0080

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

On November 2, 2010, Advance Nanotech, Inc. (the “Company”) issued a press release with a letter to shareholders from its Principal Executive Officer to update shareholders on recent developments and strategies going forward (the “Shareholder Letter”). A copy of the Shareholder Letter is furnished as Exhibit 99.1 ~~to this Current Report on Form 8-K and is incorporated herein by reference.~~

~~The information furnished pursuant to~~ Item 72.~~01, including Exhibit 99~~02.1, ~~shall~~Results ~~not be deemed to be “filed” for purposes~~ of ~~Section~~Operations 18and ofFinancial the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filingCondition.

~~Statements~~Advance ~~in this Report and the Shareholder Letter~~Nanotech, ~~other than historical information, consists of forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934~~Inc. ~~These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Although~~ (the “Company”) ~~believes~~issued ~~that~~a ~~the~~press ~~expectations~~release ~~reflected~~on inNovember ~~such forward-looking statements are reasonable~~16, it2010 ~~can~~announcing ~~give no assurance that such expectations will prove to have been correct. Important factors, including general economic conditions, spending levels, market acceptance of product lines,~~ the recent economic slowdown affecting technology companies, the future success of scientific studies, ability to successfully develop products, rapid technological change, changes in demand for future products, legislative, regulatory and competitive developments and other factors could cause actual results to differ materially from the Company~~'s expectations. Advance Nanotech~~’s ~~Annual~~results ~~Report~~of onoperations ~~Form~~for ~~10-K, recent and forthcoming Quarterly Reports on Form 10-Q, and recent Current Reports and other SEC filings discuss some of~~ the ~~important~~quarter ~~risk~~ended ~~factors~~September ~~that may affect Advance Nanotech’s business~~30, ~~results of operations and financial condition~~2010. The ~~Company~~press ~~undertakes~~release nois ~~obligation~~attached toas ~~revise~~Exhibit or99.1 ~~update~~hereto ~~publicly~~and ~~any~~is ~~forward-looking~~incorporated ~~statements~~herein ~~for~~in ~~any~~its ~~reason~~entirety.

The information included in this Item 2.02 of Current Report on Form 8-K, including the attached Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01

Financial Statements and Exhibits.

d)	Exhibits
Exhibit Number		Description
99.1		~~Shareholder~~Press ~~Letter~~Release, ~~Dated~~dated November 216, 2010.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ADVANCE NANOTECH, INC. By: /s/ Jon Buttles Name: Jon Buttles Title: Principal Executive Officer


	ADVANCE NANOTECH, INC.

	By:	/s/ Jon Buttles
		Name: Jon Buttles Title: Principal Executive Officer
Dated: November 18, 2010

~~Dated: November 4, 2010~~2

EXHIBIT INDEX

Exhibit No.		Description
99.1		~~Shareholder~~Press ~~Letter~~Release, dated November 216, 2010 *

* Furnished herewith

Filing Compare · Advance Nanotech, Inc.